China’s WuXi to sell Advanced Therapies unit amid US restrictions
(Reuters) -China’s WuXi AppTec said on Tuesday its subsidiaries have signed a deal with U.S.-based private equity firm Altaris LLC for the sale of its cell and gene therapy manufacturing unit, WuXi Advanced Therapies, for an undisclosed sum. The company, along with other Chinese firms, have been at the center of new U.S. laws aimed…